NOTES TO CONDENSED
FINANCIAL STATEMENTS
UNAUDITED
NOTE 1
ORGANIZATION AND BASIS OF PRESENTATION
Organization and Nature of Business
Code Green Apparel Corp. (the “
Company
”)
was incorporated in Nevada on December 11, 2007. On April 26, 2014, and with the appointment of George Powell as its CEO and Director,
the Company changed its business model to offer eco-friendly corporate apparel primarily constructed from recycled textiles.
The Company is a publicly held Nevada corporation,
whose common stock trades on the OTC Market Group, Inc.’s Pink Sheets under the trading symbol, “
CGAC.
”
Basis of Presentation
The accompanying unaudited interim condensed financial
statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“
GAAP
”)
for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do
not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management,
all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating
results for the periods presented are not necessarily indicative of the results that may be expected for the year ending December
31, 2017. For further information, refer to the financial statements and footnotes thereto included in the Company’s
annual report on Form 10-K for the year ended December 31, 2016.
Use of Estimates
The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America requires management to make certain estimates and
assumptions that affect the reported amounts and timing of revenues and expenses, the reported amounts and classification of assets
and liabilities, and the disclosure of contingent assets and liabilities. These estimates and assumptions are based on the Company’s
historical results as well as management’s future expectations. The Company’s actual results could vary
materially from management’s estimates and assumptions. Additionally, interim results may not be indicative of the
Company’s results for future interim periods, or the Company’s annual results.
Cash and Cash Equivalents
Cash and cash equivalents include cash on hand
and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months
or less. At March 31, 2017, the company did not have any cash equivalents.
Accounts Receivable
Accounts receivable are not collateralized and
interest is not accrued on past due accounts. Periodically, management reviews the adequacy of its provision for doubtful accounts
based on historical bad debt expense results and current economic conditions using factors based on the aging of its accounts receivable.
After management has exhausted all collection efforts, management writes off receivables and the related reserve. Additionally,
the Company may identify additional allowance requirements based on indications that a specific customer may be experiencing financial
difficulties. Actual bad debt results could differ materially from these estimates.
Inventories
Inventories are stated at the lower of cost (first-in,
first-out) or market. The Company periodically reviews its inventories for indications of slow movement and obsolescence and records
an allowance when it is deemed necessary.
Revenue Recognition
The Company recognizes gross sales when persuasive
evidence of an arrangement exists, title transfer has occurred, the price is fixed or readily determinable, and collection is probable.
It recognizes revenue in accordance with Accounting Standards Codification (“
ASC
”) 605, Revenue
Recognition (“
ASC 605
”).
Stock Based Compensation
The Company from time to time issues shares of
common stock for services. These issuances have been valued based upon the quoted market price of the shares.
Disclosure About Fair Value of Financial Instruments
The Company estimates that the fair value of all
financial instruments at March 31, 2017 and December 31, 2016, do not differ materially from the aggregate carrying values of its
financial instruments recorded in the accompanying condensed balance sheets. The estimated fair value amounts have been determined
by the Company using available market information and appropriate valuation methodologies. Considerable judgment is required in
interpreting market data to develop the estimates of fair value, and accordingly, the estimates are not necessarily indicative
of the amounts that the Company could realize in a current market exchange.
Derivative Financial Instruments
The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial
instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then
re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative
financial instruments, the Company uses the Black-Scholes-Merton pricing model to value the derivative instruments. The classification
of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the
end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based
on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
The Company has determined that certain convertible
debt instruments outstanding as of the date of these financial statements include an exercise price “
reset
”
adjustment that qualifies as derivative financial instruments under the provisions of ASC 815-40, Derivatives and Hedging - Contracts
in an Entity’s Own Stock (“
ASC 815-40
”). Certain of the convertible debentures have
a variable exercise price, thus are convertible into an indeterminate number of shares for which we cannot determine if we have
sufficient authorized shares to settle the transaction with. Accordingly, the embedded conversion option is a derivative liability
and is marked to market through earnings at the end of each reporting period. Any change in fair value during the period recorded
in earnings as “
Other income (expense) - gain (loss) on change in derivative liabilities.
”
|
|
Carrying Value
|
|
|
Fair Value Measurements
Using Fair Value Hierarchy
|
|
|
|
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Derivative liability – December 31, 2016
|
|
$
|
1,525,135
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,525,135
|
|
Derivative liability – March 31, 2017
|
|
$
|
1,251,179
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,251,179
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,525,135
|
|
Revaluation due to insufficient shares available for issuance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(561,447
|
)
|
Conversion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(56,758
|
)
|
Change in derivative liability during the three months March 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
344,249
|
|
Balance March 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,251,179
|
|
Net Income (Loss) Per Share
Basic earnings (loss) per share is computed by
dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the
period. Diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts to
issue common stock were exercised or converted into common stock. Any anti-dilutive effects on net income (loss) per share are
excluded. The Company has 534,399,820 potentially dilutive securities outstanding as of March 31, 2017.
Income Taxes
The Company accounts for income taxes in accordance
with FASB ASC 740, “
Income Taxes,
” which requires that the Company recognize deferred tax liabilities
and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities,
using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results
from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely
than not that some or all deferred tax assets will not be realized.
The Company has adopted the provisions of FASB
ASC 740-10-05
Accounting for Uncertainty in Income Taxes
. The ASC clarifies the accounting for uncertainty in income taxes
recognized in an enterprise’s financial statements. The ASC prescribes a recognition threshold and measurement attribute
for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The ASC
provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
Open tax-years subject to IRS examination include 2013 - 2016.
Recent Accounting
Pronouncements
In February 2016, the FASB issued ASU No. 2016-02,
Leases (Topic 842) to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities
on the balance sheet and disclosing key information about leasing arrangements. Topic 842 affects any entity that enters into a
lease, with some specified scope exemptions. The guidance in this ASU supersedes Topic 840, Leases. The core principle of Topic
842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement
of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right
to use the underlying asset for the lease term. For public companies, the amendments in this ASU are effective for fiscal years
beginning after December 15, 2018, including interim periods within those fiscal years. We are currently evaluating the impact
of adopting ASU No. 2016-02 on our financial statements.
In March
2016, the FASB issued ASU 2016-08,
Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations
(Reporting Revenue Gross versus Net)
that clarifies how to apply revenue recognition guidance related to whether an entity
is a principal or an agent. ASU 2016-08 clarifies that the analysis must focus on whether the entity has control of the goods or
services before they are transferred to the customer and provides additional guidance about how to apply the control principle
when services are provided and when goods or services are combined with other goods or services. The effective date for ASU 2016-08
is the same as the effective date of ASU 2014-09
as amended by ASU 2015-14
,
for
annual reporting periods beginning after December 15, 2017, including interim periods
within
those years.
The Company has not yet determined the impact of
ASU 2016-08 on its financial
statements.
In March 2016, the FASB issued ASU No. 2016-09,
Compensation – Stock Compensation, or ASU No. 2016-09. The areas for simplification in this ASU involve several aspects of
the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either
equity or liabilities, and classification on the statement of cash flows. For public entities, the amendments in this ASU are effective
for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted
in any interim or annual period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected
as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of
the amendments in the same period. Amendments related to the timing of when excess tax benefits are recognized, minimum statutory
withholding requirements, forfeitures, and intrinsic value should be applied using a modified retrospective transition method by
means of a cumulative-effect adjustment to equity as of the beginning of the period in which the guidance is adopted. Amendments
related to the presentation of employee taxes paid on the statement of cash flows when an employer withholds shares to meet the
minimum statutory withholding requirement should be applied retrospectively. Amendments requiring recognition of excess tax benefits
and tax deficiencies in the income statement and the practical expedient for estimating expected term should be applied prospectively.
An entity may elect to apply the amendments related to the presentation of excess tax benefits on the statement of cash flows using
either a prospective transition method or a retrospective transition method.
In April 2016, the FASB issued ASU 2016-10,
Revenue
from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing
, which provides further guidance
on identifying performance obligations and improves the operability and understandability of licensing implementation guidance.
The effective date for ASU 2016-10 is the same as the effective date of ASU 2014-09 as amended by ASU 2015-14
,
for annual reporting periods beginning after December 15, 2017, including interim periods
within
those years.
The Company has not yet determined the impact of
ASU 2016-10 on its financial
statements.
NOTE 2
PROPERTY AND EQUIPMENT, NET
Property and equipment consists of the following:
|
|
March 31, 2017
|
|
|
December 31, 2016
|
|
|
|
|
|
|
|
|
Computer equipment
|
|
$
|
16,783
|
|
|
$
|
16,783
|
|
|
|
|
16,783
|
|
|
|
16,783
|
|
Less accumulated depreciation
|
|
|
(4,661
|
)
|
|
|
(3,821
|
)
|
Total
|
|
$
|
12,122
|
|
|
$
|
12,962
|
|
The aggregate depreciation charge to operations
was $840 and $658 for the three months ended March 31, 2017 and 2016, respectively. The depreciation policies followed by the Company
are described in Note 1.
NOTE 3
NOTES PAYABLE
During June 2016, the Company issued a $200,000
promissory note in connection with the Asset Purchase Agreement, see Note 9. The note carries interest at 10% per annum and is
due June 23, 2018. Total outstanding debt was $200,000 and $200,000 at March 31, 2017 and December 31, 2016, respectively. The
accrued interest on the note was $15,397 and $10,466 at March 31, 2017 and December 31, 2016, respectively.
During July 2016, the Company issued a promissory
note in the amount of $82,500. The note is currently in default. The note contains an original issue discount in the amount of
$7,500. The remaining balance due at March 31, 2017 and December 31, 2016 was $82,500 and $82,500, respectively. The accrued interest
on the note was $26,238 and $8,945 at March 31, 2017 and December 31, 2016, respectively.
During September 2016, the Company issued a promissory
note in the amount of $10,000. The note is due in six months. The note contains an original issue discount in the amount of $650.
The remaining balance due at March 31, 2017 and December 31, 2016 was $-0- and $95, respectively. Interest accrues at 12% and is
paid daily. The accrued interest on the note was $-0- and $-0- at March 31, 2017 and December 31, 2016, respectively. The balance
of this note was paid in February 2017.
During January 2017, the Company issued a promissory
note in the amount of $20,000. The note was due February 15, 2017. The note requires an interest payment of $5,000 upon repayment.
The remaining balance due at March 31, 2017 and December 31, 2016 was $20,000 and $-0-, respectively. The accrued interest on the
note was $5,000 and $-0- at March 31, 2017 and December 31, 2016, respectively. The balance of this note and accrued interest was
paid in April 2017.
NOTE 4
CONVERTIBLE NOTES
On May 1, 2014, the Company entered into an agreement
with Anubis Capital Partners, a business advisor. The agreement calls for monthly payments of $2,500 in service fees along with
the issuance of a $500,000 fully earned convertible debt that accrues interest at 8% per annum. The holder has the option to convert
any balance of principal and interest into common stock of the Company. The rate of conversion for the note is calculated as the
lowest of the 20 trading closing prices immediately preceding such conversion, discounted by 50%. During December 2015, the Company
issued 25,000,000 shares of common stock in payment of $212,500 of principal on this convertible debt. At March 31, 2017 and December
31, 2016, $20,000 and $20,000 was owed in services fees, accrued interest was $94,403 and $88,795 and the outstanding convertible
debt was $261,500 and $287,500, respectively.
During the year ended December 31, 2014, the Company
issued $173,500 of convertible notes. The convertible notes carry interest at 10% per annum and are due 24 months from the date
of issuance, June 2016 through September 2016. The note holders have the option to convert into shares of the Company’s
common stock after 180 days at 50% of the market price. During April and May of 2015, the Company issued 14,660,440 shares of common
stock upon conversion of $173,500 of principal amount outstanding under these convertible notes. Total outstanding convertible
debt was $-0- and $-0- at March 31, 2017 and December 31, 2016, respectively. At March 31, 2017 and December 31, 2016, the accrued
interest on the convertible notes was $12,027 and $12,027, respectively.
During December 2015, the Company issued
a convertible note in the amount of $175,000. The convertible note was due in one year and is currently in default, and
contains a prepayment penalty of $25,000. The holder has the option to convert any balance of principal into common stock of
the Company. The rate of conversion for the note is calculated as the lowest of the 10 trading closing prices
immediately preceding such conversion, discounted by 32.5%. During December 2016, the Company issued 12,000,000 shares of
common stock upon conversion of $13,770 of principal amount outstanding under this convertible note. The remaining balance
due at March 31, 2017 and December 31, 2016 was $161,730 and $161,730, respectively.
During June 2016, the Company sold a convertible
note in the principal amount of $121,325. The convertible note is due in one year and contains an original issue discount in the
amount of $15,825. The holder has the option to convert any balance of principal into common stock of the Company after the initial
180 days. The rate of conversion for this note is calculated as the average of the three lowest closing prices of the Company’s
common stock during the 20 trading days immediately preceding such conversion, discounted by 50%. The remaining balance due at
March 31, 2017 and December 31, 2016 was $65,884 and $73,989, respectively. Interest accrues at 12% per annum and is paid daily.
The accrued interest on the note was $-0- and $-0- at March 31, 2017 and December 31, 2016, respectively.
During September 2016, the Company sold a convertible
note in the principal amount of $63,825. The convertible note is due in one year and contains an original issue discount in the
amount of $13,825. The holder has the option to convert any balance of principal into common stock of the Company after the initial
180 days. The rate of conversion for this note is calculated as the average of the three lowest closing prices of the Company’s
common stock during the 20 trading days immediately preceding such conversion, discounted by 50%. The remaining balance due at
March 31, 2017 and December 31, 2016 was $49,380 and $53,481, respectively. Interest accrues at 12% per annum and is paid daily.
The accrued interest on the note was $-0- and $-0- at March 31, 2017 and December 31, 2016, respectively.
Derivative Liability
On May 1, 2014, the Company secured $500,000 in
the form of a convertible promissory note. The note bears interest at the rate of 8% per annum until it matures, or until there
is an event of default. The note matured on May 1, 2015. The holder has the option to convert any balance of principal and interest
into common stock of the Company. The rate of conversion for the note is calculated as the lowest of the 20 trading closing prices
immediately preceding such conversion, discounted by 50%. A total of $287,500 remains outstanding as of December 31, 2016, and
a total of $212,500 was converted into shares of common stock.
On December 3, 2015, the Company secured $175,000
in the form of a convertible promissory note. The note does not bear interest until or unless there is an event of default. The
note matured on December 3, 2016. The holder has the option to convert any balance of principal into common stock of the Company.
The rate of conversion for the note is calculated as the lowest of the 10 trading closing prices immediately preceding such conversion,
discounted by 32.5%.
On June 15, 2016, the Company secured $121,325
in the form of a convertible promissory note. The note bears interest at 12% per annum. The note matures on June 15, 2017. The
holder has the option to convert any balance of principal into common stock of the Company after the initial 180 days. The rate
of conversion for this note is calculated as the average of the three lowest closing prices of the Company’s common
stock during the 20 trading days immediately preceding such conversion, discounted by 50%.
On September 23, 2016, the Company secured $63,825
in the form of a convertible promissory note. The note bears interest at 12% per annum. The note matures on September 23, 2017.
The holder has the option to convert any balance of principal into common stock of the Company after the initial 180 days. The
rate of conversion for this note is calculated as the average of the three lowest closing prices of the Company’s
common stock during the 20 trading days immediately preceding such conversion, discounted by 50%.
Due to the variable conversion price associated
with these convertible promissory notes, the Company has determined that the conversion feature is considered a derivative liability.
The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives
as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date.
The initial fair values of the embedded debt derivatives
of $500,842, $227,746, $322,660 and $108,458 were charged to current period operations as interest expenses. The fair value of
the described embedded derivative was determined using the Black-Scholes Model with the following assumptions:
(1) risk free interest rate of
|
0.10% to 0.45%
|
(2) dividend yield of
|
0%;
|
(3) volatility factor of
|
248% to 435%;
|
(4) an expected life of the conversion feature of
|
365 days; and
|
(5) estimated fair value of the Company’s common stock of
|
$0.006 to $0.008 per share.
|
During the three months ended March 31, 2017, the
Company recorded a gain on fair value of derivative of $84,603.
The following table represents the Company’s
derivative liability activity for the three months ended March 31, 2017:
Balance at December 31, 2016
|
|
$
|
1,525,135
|
|
Revaluation due to insufficient shares available for issuance
|
|
|
(561,447
|
)
|
Conversion
|
|
|
(56,758
|
)
|
Change in derivative liability during the three months ended March 31, 2017
|
|
|
344,249
|
|
Balance
March 31, 2017
|
|
$
|
1,251,179
|
|
NOTE 5
DERIVATIVE FINANCIAL INSTRUMENTS
The following table presents the components of
the Company’s derivative financial instruments associated with convertible promissory notes (See Note 4) which have
no observable market data and are derived using the Black-Scholes option pricing model measured at fair value on a recurring basis,
using Level 1 and 3 inputs to the fair value hierarchy, at March 31, 2017 and December 31, 2016:
|
|
March 31, 2017
|
|
|
December 31, 2016
|
|
Embedded conversion features
|
|
$
|
1,251,179
|
|
|
$
|
963,688
|
|
Insufficient shares
|
|
|
—
|
|
|
|
561,447
|
|
Derivative liability
|
|
$
|
1,251,179
|
|
|
$
|
1,525,135
|
|
These derivative financial instruments arise as a result of applying
ASC 815 Derivative and Hedging
(“
ASC
815
”), which requires the Company to make a determination whether an equity-linked financial instrument, or embedded
feature, is indexed to the entity’s own stock. This guidance applies to any freestanding financial instrument or embedded
features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled
in an entity’s own stock.
During the three months ended March 31, 2017, the
Company had outstanding notes with embedded conversion features and the Company did not, at this date, have a sufficient number
of authorized and available shares of common stock to settle the outstanding contracts which triggered the requirement to account
for these instruments as derivative financial instruments until such time as the Company has sufficient authorized shares.
NOTE 6
LEASE COMMITMENTS
Laguna Beach Office
The Company is obligated under a commercial real
estate lease agreement. The lease is for a term of 60 months which began February 1, 2016 and expires January 31, 2021. The lease
calls for current monthly rental payments of $3,438.
Dallas Office
The Company is obligated under a commercial real
estate sublease agreement. The sublease is for a term of seven months which began on August 1, 2016 and expires on February 28,
2017. The lease calls for current monthly rental payments of $2,200.
Rental expense for the three months ended March
31, 2017 and 2016 was $7,134 and $13,254, respectively. Future minimum rental payments for the remaining terms are as follows:
Year Ending December 31,
|
|
|
Amount
|
|
2018 – remaining nine months
|
|
|
$
|
30,942
|
|
2019
|
|
|
|
41,256
|
|
2020
|
|
|
|
41,256
|
|
2021
|
|
|
|
3,438
|
|
Total
|
|
|
$
|
116,892
|
|
NOTE 7
STOCKHOLDERS’ EQUITY
On January 9, 2017, the
Company issued 10,000,000 shares of its restricted common stock to its then newly appointed Director and COO, as a signing bonus
for his appointment to the Company’s Board of Directors. The shares had a fair market value of $30,000.
On February 9, 2017, the Company entered into an
Advertising Services Agreement (the “
Advertising Agreement
”) with Cicero Consulting Group, LLC
(“
Cicero
”), pursuant to which Cicero agreed to provide marketing and advertising services to the
Company for a term of six months. In consideration for agreeing to provide those services the Company agreed to issue Cicero 32
million shares of common stock. The value of the 32,000,000 shares is $96,000. Due to the terms of the agreement, $32,000 has been
recorded in the statement of operations for the three months ended March 31, 2017 and $64,000 remains as prepaid expense to be
amortized through July 2017.
On March 22, 2017, we
issued 20 million shares of common stock to Anubis Capital Partners in connection with the conversion of debt valued at $26,000.
Series A Preferred Stock
On May 22, 2015, the Company designated a series
of Series A Preferred Stock. The holders of the Series A Preferred Stock are not entitled to receive dividends paid on the Company’s
common stock. The holders of the Series A Preferred Stock are not entitled to any liquidation preferences. The shares of the Series
A Preferred Stock have no conversion rights. The Series A Preferred Stock provide the holder thereof the power to vote on all shareholder
matters (including, but not limited to at every meeting of the stockholders of the Company and upon any action taken by stockholders
of the Company with or without a meeting) equal to fifty-one percent (51%) of the total vote. Following the third anniversary of
the original issuance of the Series A Preferred Stock, the Company has the option with (a) the unanimous consent or approval of
all members of the Board of Directors of the Company; (b) the approval of the holders of a majority of the outstanding shares of
Series A Preferred Stock; and (c) the approval of any interest or option holder(s) of such Series A Preferred Stock, to redeem
any and all outstanding shares of the Series A Preferred Stock by paying the holders a redemption price of $100 per share.
Series B Preferred Stock
On December 7, 2015, the Company designated a series
of Series B Preferred Stock. The Series B Preferred Stock have an original issue price and liquidation preference (pro rata with
the common stock) of $10.00 per share. The Series B Preferred Stock provides the holders thereof the right to convert such shares
of Series B Preferred Stock into common stock on a 100-for-one basis, provided that no conversion can result in the conversion
of more than that number of shares of Series B Preferred Stock, if any, such that, upon such conversion, the aggregate beneficial
ownership of the Company’s common stock of any such holder and all persons affiliated with any such holder as described
in Rule 13d-3 is more than 4.99% of the Company’s common stock then outstanding (the “
Maximum Percentage
”).
For so long as any shares of the Series B Convertible Preferred Stock remain issued and outstanding, the holders thereof are entitled
to vote that number of votes as equals the number of shares of common stock into which such holder’s aggregate shares
of Series B Convertible Preferred Stock are convertible, subject to the Maximum Percentage.
On December 7, 2015, the Company entered into an
Exchange Agreement (the “
Exchange
”) with its shareholder, Dr. Eric H. Scheffey, whereby Dr. Scheffey
exchanged forty million (40,000,000) shares of the Company’s restricted common stock for 40,000 shares of the Company’s
Series B Preferred Stock.
On January 4, 2016, the
Company sold 25,000 shares of its restricted Series B Preferred Stock in connection with a Subscription Agreement dated December
7, 2015 (the January 1, 2016 payment) and received $250,000. The intrinsic value, the difference between the subscription price
and the underlying price of the common stock on the date of the subscription agreement, has been valued at $250,000. Accordingly,
this Discount attributable to beneficial conversion privilege of preferred stock has been recorded as a dividend in the current
period and an increase in additional paid-in capital.
NOTE 8 GOING
CONCERN
The accompanying consolidated
financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the
realization of assets and the liquidation of liabilities in the normal course of business. The Company has had only limited
revenues since inception. Since inception, it has incurred significant losses to date, and as of March 31, 2017, has an
accumulated deficit of approximately $14,400,000 and has negative working capital of $2,362,000. These factors raise
substantial doubt about the Company's ability to continue as a going concern. The Company’s ability to continue its
operations is uncertain and is dependent upon its ability to implement a business plan sufficient to generate a positive cash
flow and/or raise capital to fund its operations. These financial statements do not include any adjustments to the amounts
and classifications of assets and liabilities that might be necessary should the Company be unable to continue operations in
the normal course of business.
NOTE 9
ASSET PURCHASE AGREEMENT
Effective on June 23, 2016, the Company entered
into an Asset Purchase Agreement with 10Star LLC (“
10Star
” and the “
Purchase Agreement
”),
pursuant to which, the Company purchased certain contracts, relating to 10Star’s “
On the Border
”
and “
7-Eleven
” accounts (the “
Purchased Accounts
”).
The purchase price paid for the Assets at closing
on June 23, 2016, was (a) $50,000 in cash; (b) 5 million shares of restricted common stock; and (c) a promissory note in the amount
of $200,000 (the “
Promissory Note
”). During December 2016, the asset value of $280,000 was considered
fully impaired. As such, the entire value of $280,000 less the accumulated amortization in the amount of $60,000, was written off.
Amounts due under the Promissory Note accrue interest
at the rate of 10% per annum (12% upon the occurrence of an event of default), with all interest payable on the maturity date of
the Promissory Note, June 23, 2018, provided that the amounts owed under the Promissory Note can be pre-paid in whole or part at
any time prior to maturity. Until the earlier of (a) the maturity date of the Promissory Note; and (b) the date the Promissory
Note is paid in full, we are required to pay 10Star fifty percent (50%) of the Gross Profits generated by us in connection with
the Purchased Accounts, no later than the end of the calendar month following the month during which we generate such Gross Profits
and receive payment in connection therewith. “
Gross Profit
” means: (x) the total gross revenues
derived from the Purchased Accounts, less (y) (i) cost of goods sold, (ii) returns, (iii) discounts, (iv) adjustments, and (v)
allowances, and those other items that are customarily subtracted from total gross revenue to determine gross profit in accordance
with generally accepted accounting principles (“
GAAP
”). Each payment is credited first to accrued
interest and second to principal. The Promissory Note contains standard and customary events of default. The Promissory Note is
unsecured and 10Star has no right to any collateral or security interests in connection therewith.
NOTE
10
|
EMPLOYMENT
AGREEMENTS
|
As
part of, and as a required term and condition of the Purchase Agreement, the Company entered into executive employment agreements
with Aaron Luna and William Joseph (J.B.) Hill, to serve as Executive Vice Presidents of the Company in May 2016, in anticipation
of the Acquisition.
The
employment agreements each have substantially similar terms, including an effective date of April 1, 2016, an initial term of
one year (automatically renewable thereafter for additional one year terms in the event neither party provides the other notice
of non-renewal at least 30 days prior to the end of the then term). Both agreements include a base salary as determined by the
Board of Directors in its sole and absolute discretion in addition to an equity consideration of 3.75 million restricted shares
of common stock to Mr. Luna and 3.25 million restricted shares of common stock to Mr. Hill (the “
Restricted Shares
”),
which Restricted Shares are subject to forfeiture and cancellation until March 31, 2017, pursuant to Restricted Stock Award Agreements.
In addition to the base salary described above, the executives were to receive a commission on our net sales.
Both
Mr. Luna and Mr. Hill subsequently terminated their services with the Company in October 2016, and all Restricted Shares have
been forfeited, provided that such shares have not yet been cancelled to date.
NOTE
11
|
SUBSEQUENT
EVENTS
|
On
April 12, 2017, our Board of Directors and majority shareholder (i.e., George J. Powell, III, the Company’s Chief Executive
Officer and Director, who holds (i) 1,000 shares of Series A Preferred Stock, which provides the holder thereof the right to vote
51% of the vote on all shareholder matters and (ii) 89,115,016 shares of the Company’s outstanding common stock), via a
written consent to action without meeting, approved the filing of a Certificate of Amendment to our Articles of Incorporation
to increase the authorized common stock of the Company, from one billion (1,000,000,000) shares of common stock, $0.001 par value
per share, to one billion, nine hundred and ninety million (1,990,000,000) shares of common stock, $0.001 par value share (the
“
Amendment
”). The increase in authorized shares is reflected in the balance sheets.
The
Amendment did not change (a) the number of authorized shares of our preferred stock, which remained ten million (10,000,000) shares
of preferred stock, $0.001 par value per share; (b) the rights of our Board of Directors to designate the rights and preferences
of such preferred stock (as further described in our Articles of Amendment, as amended); or (c) the previously designated series
of our preferred stock.
On
April 13, 2017, the Company filed the Amendment with the Nevada Secretary of State, which became effective on the same date.
On
April 12, 2017, pursuant to a Note Purchase Agreement,
we sold a 10% Convertible
Debenture in the principal amount of $32,500 (which included a $5,000 original issue discount) to Sojourn Investments, LP (“
Sojourn
”
and the “
Sojourn Debenture
”). The principal amount of the debenture accrues at 10% per annum until paid or
converted into common stock (18% upon the occurrence of an event of default). The Sojourn Debenture has a maturity date of January
12, 2018, provided the debenture can be repaid at any time, provided that if repaid more than 30 days after the issuance date,
we are required to pay 130% of the principal amount of the debenture, together with accrued interest.
The
Sojourn Debenture is convertible into shares of our common stock at any time, at a conversion price equal to 58% of the average
of the lowest three (3) closing prices during the prior 20 trading days.
In
the event we fail to deliver the shares of common stock issuable upon conversion of the
debenture
within
three business days of our receipt of a conversion notice, we are required to pay
Sojourn
$1,000
per day for each day that we fail to deliver such shares for up to the first 30 days that the failure continues.
At
no time may the
Sojourn Debenture
be converted into shares of our common
stock if such conversion would result in
Sojourn
and its affiliates owning
an aggregate of in excess of 4.99% of the then outstanding shares of our common stock.
The
Sojourn
Debenture
provides for standard and customary events of default such as failing to timely make payments under the
Sojourn
Debenture
when due and the failure of the Company to timely comply with the Exchange Act reporting requirements. Additionally,
upon the occurrence of certain defaults, as described in the
Sojourn Debenture
,
we are required to pay
Sojourn
liquidated damages in addition to the amount
owed under the
Sojourn Debenture
.
We
hope to repay the
Sojourn Debenture
prior to any conversion. In the event
that the
Sojourn Debenture
is not repaid in cash in its entirety, Company
shareholders may suffer dilution if and to the extent that the balance of the
Sojourn
Debenture
is converted into common stock.
On
April 17, 2017, we sold Carebourn a Convertible Promissory Note in the principal amount of $135,575 (the “
April
2017 Carebourn Convertible Note
”), pursuant to a Securities Purchase Agreement, dated April 17, 2017. The April 2017
Carebourn Convertible Note bears interest at the rate of 12% per annum (22% upon an event of default) and is due and payable on
April 17, 2018. The April 2017 Carebourn Convertible Note had an original issue discount of $27,075. In addition, we paid $8,500
of Carebourn’s expenses and attorney fees in connection with the sale of the note, which were included in the principal
amount of the note.
Periodic
payments are due by us on the April 2017 Carebourn Convertible Note at the rate of $565 per day ($135,575 / 240 days)(the “
Repayment
Amount
”), via direct withdrawal from our bank account. The Repayment Amount automatically adjusts to a prorated higher
amount in the amount any penalties or events of default occur under the April 2017 Carebourn Convertible Note.
The
April 2017 Carebourn Convertible Note provides for standard and customary events of default such as failing to timely make payments
under the April 2017 Carebourn Convertible Note when due, the failure of the Company to timely comply with the Exchange Act reporting
requirements and the failure to maintain a listing on the OTCQB. Additionally, upon the occurrence of certain defaults, as
described in the April 2017 Carebourn Convertible Note, we are required to pay Carebourn liquidated damages in addition to the
amount owed under the April 2017 Carebourn Convertible Note.
The
principal amount of the April 2017 Carebourn Convertible Note and all accrued interest is convertible at the option of the holder
thereof into our common stock at any time following the 180th day after the April 2017 Carebourn Convertible Note was issued.
The conversion price of the April 2017 Carebourn Convertible Note is equal to 50% of the average of the lowest three (3) trading
prices of the Company’s common stock during the twenty trading days prior to the conversion date.
In
the event we fail to deliver the shares of common stock issuable upon conversion of the note within three business days of our
receipt of a conversion notice, we are required to pay Carebourn $1,500 per day for each day that we fail to deliver such shares.
At
no time may the April 2017 Carebourn Convertible Note be converted into shares of our common stock if such conversion would result
in Carebourn and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of our common stock.
We
may prepay in full the unpaid principal and interest on the April 2017 Carebourn Convertible Note, with at least 20 trading days’
notice, (a) any time prior to the 180th day after the issuance date, by paying 130% of the principal amount of the note together
with accrued interest thereon; and (b) any time after the 180th day after the issuance date and prior to the 364
th
day
after issuance, by paying 150% of the principal amount of the note together with accrued interest thereon.
The
April 2017 Carebourn Convertible Note also contains customary positive and negative covenants.
We
hope to repay the April 2017 Carebourn Convertible Note prior to any conversion. In the event that the April 2017 Carebourn Convertible
Note is not repaid in cash in its entirety, Company shareholders may suffer dilution if and to the extent that the balance of
the April 2017 Carebourn Convertible Note is converted into common stock.
On
April 7, 2017, we issued 21,481,481 shares of common stock to Anubis Capital Partners in connection with the conversion of debt.
On
April 11, 2017, we issued 32 million shares of common stock which were due pursuant to the terms of the February 9, 2017 Consulting
Agreement. These shares were valued at $0.003 per share or $96,000.